Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $275.06 in the prior trading day, CME Group Inc (NASDAQ: CME) closed at $269.15, down -2.15%. In other words, the price has decreased by -$2.15 from its previous closing price. On the day, 2.78 million shares were traded. CME stock price reached its highest trading level at $275.0 during the session, while it also had its lowest trading level at $264.54.
Ratios:
Our goal is to gain a better understanding of CME by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 25, 2025, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $300.
UBS Downgraded its Buy to Neutral on July 24, 2025, while the target price for the stock was maintained at $305.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’25 when SHEPARD WILLIAM R bought 251 shares for $278.37 per share. The transaction valued at 69,929 led to the insider holds 258,710 shares of the business.
SHEPARD WILLIAM R bought 11 shares of CME for $3,079 on Dec 30 ’25. The Director now owns 2,477 shares after completing the transaction at $278.37 per share. On Dec 11 ’25, another insider, DUFFY TERRENCE A, who serves as the Chairman and CEO of the company, sold 25,000 shares for $269.55 each. As a result, the insider received 6,738,815 and left with 65,804 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 97055424512 and an Enterprise Value of 98254929920. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.09, and their Forward P/E ratio for the next fiscal year is 23.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.17 while its Price-to-Book (P/B) ratio in mrq is 3.44. Its current Enterprise Value per Revenue stands at 15.388 whereas that against EBITDA is 21.863.
Stock Price History:
The Beta on a monthly basis for CME is 0.28, which has changed by 0.19956386 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $224.62. The 50-Day Moving Average of the stock is -1.54%, while the 200-Day Moving Average is calculated to be -0.90%.
Shares Statistics:
The stock has traded on average 1.83M shares per day over the past 3-months and 1334150 shares per day over the last 10 days, according to various share statistics. A total of 359.85M shares are outstanding, with a floating share count of 359.07M. Insiders hold about 0.42% of the company’s shares, while institutions hold 91.18% stake in the company. Shares short for CME as of 1765756800 were 6158003 with a Short Ratio of 3.37, compared to 1763078400 on 5410273. Therefore, it implies a Short% of Shares Outstanding of 6158003 and a Short% of Float of 1.71.
Dividends & Splits
In the trailing 12 months, CME’s forward annual dividend rate was 4.9, compared to 5.00 this year. Against a Trailing Annual Dividend Yield of 0.017814295. The stock’s 5-year Average Dividend Yield is 3.45. The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-12-12 with an ex-dividend date of 2025-12-12. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 12.0 analysts currently analyzing and rating the stock of CME Group Inc (CME).The consensus estimate for the next quarter is $2.94, with high estimates of $3.11 and low estimates of $2.76.
Analysts are recommending an EPS of between $11.33 and $10.98 for the fiscal current year, implying an average EPS of $11.18. EPS for the following year is $11.67, with 15.0 analysts recommending between $12.25 and $11.15.
Revenue Estimates
7 analysts predict $1.64B in revenue. The current quarter. It ranges from a high estimate of $1.68B to a low estimate of $1.57B. As of. The current estimate, CME Group Inc’s year-ago sales were $1.53BFor the next quarter, 7 analysts are estimating revenue of $1.7B. There is a high estimate of $1.75B for the next quarter, whereas the lowest estimate is $1.63B.
A total of 13 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.62B, while the lowest revenue estimate was $6.4B, resulting in an average revenue estimate of $6.52B. In the same quarter a year ago, actual revenue was $6.13BBased on 13 analysts’ estimates, the company’s revenue will be $6.82B in the next fiscal year. The high estimate is $7.11B and the low estimate is $6.57B.
